Effect on Exercise Endurance and Lung Hyperinflation of Tiotropium + Olodaterol in COPD Patients
Status:
Completed
Trial end date:
2013-11-01
Target enrollment:
Participant gender:
Summary
The primary objective of this trial is to investigate the effect of 6 weeks treatment with
tiotropium + olodaterol fixed dose combination inhalation solution on lung hyperinflation and
exercise tolerance in patients with COPD